Compile Data Set for Download or QSAR
Found 40 with Last Name = 'christner' and Initial = 'c'
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi:  3.40E+3nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of human FK506 binding protein 12 (Conc=14 nM) of FKBPsfamilyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP4(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi:  2.42E+4nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of rabbit FK506 binding protein 52 (Conc=52 nM) of FKBPsfamilyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP14(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi:  7.62E+4nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of Photobacterium sp. FK506 binding protein 22 (Conc=41 nM) of FKBPsfamilyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP3(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi:  1.24E+5nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of L. pneumophilia FK506 binding protein 25 (Conc=40 nM) of FKBPsfamilyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase NIMA-interacting 4(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi:  1.87E+5nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of E. coli parvulin (Conc=4 nM) of Parvulins sfamilyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataKi: >2.00E+5nMAssay Description:Inhibition constant(Ki) for inhibition of PPIase activity of human Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Conc=4 nM) of Parvulins fa...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423721(CHEMBL595105)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141972(US8927534, 11)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141975(US8927534, 20)copy SMILES
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141976(US8927534, 23)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141978(US8927534, 29)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141994(US8927534, 269)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141973(US8927534, 114 | US8927534, 83)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141979(US8927534, 75)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423736(CHEMBL591543)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141986(US8927534, 262)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141990(US8927534, 266)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141981(US8927534, 120)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141994(US8927534, 269)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141990(US8927534, 266)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141986(US8927534, 262)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423736(CHEMBL591543)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141973(US8927534, 114 | US8927534, 83)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141979(US8927534, 75)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141978(US8927534, 29)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141976(US8927534, 23)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141975(US8927534, 20)copy SMILES
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141972(US8927534, 11)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423721(CHEMBL595105)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141981(US8927534, 120)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080528(3-((R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)...)copy SMILEScopy InChI
Affinity DataIC50: 3.60E+3nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080534(CHEMBL333448 | ethyl (4-{(2R)-2-[(1S,3S,5S)-3,5-di...)copy SMILEScopy InChI
Affinity DataIC50: 4.40E+3nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080531(2-{4-[(R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxo-cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 2.16E+4nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080530(4-{4-[(R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxo-cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 2.23E+4nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080532(4-{4-[(R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxo-cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 6.82E+4nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080535(1-Benzyl-4-[(R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxo-c...)copy SMILEScopy InChI
Affinity DataIC50: 1.17E+5nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080527(4-[(R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxo-cyclohexyl...)copy SMILEScopy InChI
Affinity DataIC50: 1.24E+5nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080536(4-((R)-2-Hydroxy-2-{(1R,3S,5S)-2-[(Z)-hydroxyimino...)copy SMILEScopy InChI
Affinity DataIC50: 1.77E+5nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080529(Acetic acid (R)-1-((1S,3S,5S)-3,5-dimethyl-2-oxo-c...)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+5nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Max-Planck Research Unit

Curated by ChEMBL
LigandPNGBDBM50080533(CHEMBL331865 | {4-[(R)-2-(Adamantan-1-ylcarbamoylo...)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+5nMAssay Description:Compound was evaluated for its inhibitory effect on human FK506 binding protein 12 by means of protease-coupled PPIase assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB8124PubMed